Stock 688566 JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Jiangsu Jibeier Pharmaceutical Co., Ltd.

Equities

688566

CNE100004041

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 16/07/2024 am IST 		5-day change 1st Jan Change
21.35 CNY -0.23% Intraday chart for Jiangsu Jibeier Pharmaceutical Co., Ltd. -0.84% -31.98%
05/06 Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it has received CNY 198.161716 million in funding from a group of investors CI
21/05 Jibeier Pharmaceutical Gets Patents for Two Products MT

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
JIANGSU JIBEIER PHARMACEUTICAL CO., LTD. Stock Jiangsu Jibeier Pharmaceutical Co., Ltd.
-31.98% 558M -
MERCK KGAA Stock Merck KGaA
+6.73% 72.01B
A
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+30.80% 10.39B
A-
YUHAN CORPORATION Stock Yuhan Corporation
+41.28% 5.26B
B-
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-18.53% 4.64B
A-
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+18.24% 3.7B -
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+27.58% 2.3B - -
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-39.52% 1.8B
C-
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-45.87% 1.7B -
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B - -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
-
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. 688566 Stock
  4. Ratings Jiangsu Jibeier Pharmaceutical Co., Ltd.